IQVIA HOLDINGS INC., DEF 14A filed on 2/23/2024
Proxy Statement (definitive)
v3.24.0.1
Cover
 12 Months Ended
Dec. 31, 2023
Cover [Abstract]  
Document Type DEF 14A
Entity Registrant Name IQVIA HOLDINGS INC.
Entity Central Index Key 0001478242
Amendment Flag false
v3.24.0.1
Pay vs Performance Disclosure
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Pay vs Performance Disclosure [Table]        
Pay vs Performance [Table Text Block]

Pay versus Performance

 

The following table reports the compensation of our Principal Executive Officer (PEO) and the average compensation of the other Named Executive Officers (Other NEOs) as reported in the Summary Compensation Table for the past four fiscal years, as well as their “compensation actually paid” as calculated pursuant to recently adopted SEC rules and certain performance measures required by the rules.

 

         Average  Average  Value of Initial Fixed $100
Investment Based On(4):		     Company-
Selected
Measure(5)
Year  Summary
Compensation
Table Total for
PEO(1)		  Compensation
Actually Paid
to PEO(2)(3)		  Summary
Compensation
Table Total for
Other NEOs(1)		  Compensation
Actually Paid
to Other
NEOs(2)(3)		  IQVIA’s Total
Stockholder
Return		  Peer Group
Total
Stockholder
Return		  Net Income
(millions)		  Adjusted
Diluted EPS
Growth(6)
(a)  (b)  (c)  (d)  (e)  (f)  (g)  (h)  (i)
2023  $29,151,752  $42,292,899  $4,523,047  $4,103,793  $149.75  $170.70  $1,358  0.4%
2022  $30,135,029  $5,961,064  $5,007,016  $1,702,449  $132.61  $158.40  $1,091  12.5%
2021  $28,615,851  $88,421,980  $4,395,745  $10,062,332  $182.60  $157.40  $966  40.7%
2020  $25,575,986  $44,629,998  $2,887,147  $3,051,142  $115.96  $115.30  $279  0.5%

 

(1) Ari Bousbib was our PEO for each year presented. The individuals comprising the Other NEOs for each year presented are listed below:

 

2020 2021 2022 2023
Ron E. Bruehlman Ron E. Bruehlman Ron E. Bruehlman Ron E. Bruehlman
W. Richard Staub, III W. Richard Staub, III Costa Panagos W. Richard Staub, III
Kevin C. Knightly Kevin C. Knightly Kevin C. Knightly Kevin C. Knightly
Eric M. Sherbet Eric M. Sherbet Eric M. Sherbet Eric M. Sherbet
Michael R. McDonnell     Costa Panagos

 

(2) The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v)(2)(iii) of Regulation S-K and do not reflect compensation actually earned, realized or received by the PEO or Other NEOs.  These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
(3) Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Other NEOs as set forth below.  Equity values are calculated in accordance with FASB ASC Topic 718.  Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.

 

Year  Summary
Compensation
Table Total for PEO		  Exclusion of
Change in Pension
Value for PEO		  Exclusion of Stock
Awards and Option
Awards for PEO		  Inclusion of
Pension Service
Cost for PEO		  Inclusion of Equity
Values for PEO		  Compensation
Actually Paid
to PEO
2023  $29,151,752  $(844,991)  $(21,157,852)  $258,365  $34,885,625  $42,292,899
2022  $30,135,029  $(420,742)  $(21,388,958)  $296,785  $(2,661,050)  $5,961,064
2021  $28,615,851  $(535,539)  $(18,534,470)  $314,052  $78,562,087  $88,421,980
2020  $25,575,986  $(898,824)  $(15,916,277)  $273,872  $35,595,242  $44,629,998

 

 

Year  Average Summary
Compensation
Table Total for
Other NEOs		  Average Exclusion
of Change in
Pension Value
for Other NEOs		  Average Exclusion
of Stock Awards
and Option Awards
for Other NEOs		  Average Inclusion
of Pension Service
Cost for Other
NEOs		  Average Inclusion
of Equity Values
for Other NEOs		  Average
Compensation
Actually Paid to
Other NEOs
2023  $4,523,047  $(73,164)  $(3,228,937)  $17,778  $2,865,069  $4,103,793
2022  $5,007,016  $(46,106)  $(3,363,826)  $22,217  $83,148  $1,702,449
2021  $4,395,745  $(45,384)  $(2,548,372)  $23,204  $8,237,139  $10,062,332
2020  $2,887,147  $(60,943)  $(1,728,351)  $7,049  $1,946,240  $3,051,142

 

The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:

 

Year  Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of Year
for PEO		  Change in Fair
Value from Last
Day of Prior
Year to Last Day
of Year of
Unvested Equity
Awards for PEO		  Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that Vested
During Year for
PEO		  Change in Fair
Value from Last
Day of Prior
Year to Vesting
Date of
Unvested Equity
Awards that
Vested During
Year for PEO		  Fair Value at
Last Day of Prior
Year of Equity
Awards
Forfeited During
Year for PEO		  Value of
Dividends or
Other Earnings
Paid on Stock or
Option Awards
Not Otherwise
Included for
PEO		  Total -
Inclusion of
Equity Values
for PEO
2023  $22,020,972  $1,379,297  0  $11,485,356  0  0  $34,885,625
2022  $16,869,138  $(15,553,971)  0  $(3,976,217)  0  0  $(2,661,050)
2021  $34,647,149  $25,065,538  0  $18,849,400  0  0  $78,562,087
2020  $20,767,428  $8,585,982  0  $6,241,832  0  0  $35,595,242

 

Year  Average
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of Year
for Other NEOs		  Average Change
in Fair Value
from Last Day of
Prior Year to
Last Day of Year
of Unvested
Equity Awards
for Other NEOs		  Average
Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that Vested
During Year for
Other NEOs		  Average Change
in Fair Value
from Last Day of
Prior Year to
Vesting Date of
Unvested Equity
Awards that
Vested During
Year for Other
NEOs		  Average Fair
Value at Last
Day of Prior
Year of Equity
Awards
Forfeited During
Year for Other
NEOs		  Average Value
of Dividends or
Other Earnings
Paid on Stock or
Option Awards
Not Otherwise
Included for
Other NEOs		  Total - Average
Inclusion of
Equity Values
for Other NEOs
2023  $2,411,696  $153,127  0  $1,274,065  $(973,819)  0  $2,865,069
2022  $2,660,228  $(2,066,942)  0  $(510,138)  0  0  $83,148
2021  $4,763,789  $2,005,653  0  $1,467,697  0  0  $8,237,139
2020  $1,707,797  $336,729  0  $149,599  $(247,885)  0  $1,946,240

(4) The peer group for each listed fiscal year consists of the companies listed as our compensation benchmarking peer group in the Compensation Discussion & Analysis specific for that fiscal year. For 2020 and 2021 the companies included Bausch Health Companies Inc., Boston Scientific Corporation, Cognizant Technology Solutions Corporation, Fiserv, Inc., Laboratory Corporation of America Holdings, Nielsen Holdings plc, Quest Diagnostics Incorporated, Regeneron Pharmaceuticals, Inc., Salesforce, Inc., S&P Global Inc., and Thomson Reuters Corporation (but excludes Allergan plc, acquired by AbbVie Inc. on May 8, 2020). For 2022, all of these companies were included except Nielsen Holdings plc. For 2023, the companies included AbbVie Inc., Accenture plc, Agilent Technologies, Inc., Amgen Inc., Avantor, Inc., Biogen Inc., Bristol Myers Squibb Co., Cognizant Technology Solutions Corp., Danaher Corporation, Eli Lilly & Co., Gartner, Inc., Gilead Sciences, Inc., International Business Machines Corp., ICON Plc, Laboratory Corp of America Holdings, Merck & Co., Inc., Moderna, Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals Inc., and Zoetis Inc.
(5) The Company has identified Adjusted Diluted EPS Growth as the company-selected measure for the pay versus performance disclosure, as it represents the most important financial performance measure used to link compensation actually paid to the PEO and the Other NEOs in 2023 to the Company’s performance. See Appendix A in this Proxy Statement for a reconciliation of Adjusted Diluted EPS Growth, a non-GAAP measure, to the most directly comparable GAAP measure.
(6) Adjusted Diluted EPS Growth was chosen from the following four most important financial performance measures used by the Company to link compensation actually paid to the PEO and other NEOs in 2023 to the Company’s performance:
      
Company Selected Measure Name Adjusted Diluted EPS Growth      
Named Executive Officers, Footnote [Text Block]

 

(1) Ari Bousbib was our PEO for each year presented. The individuals comprising the Other NEOs for each year presented are listed below:

 

2020 2021 2022 2023
Ron E. Bruehlman Ron E. Bruehlman Ron E. Bruehlman Ron E. Bruehlman
W. Richard Staub, III W. Richard Staub, III Costa Panagos W. Richard Staub, III
Kevin C. Knightly Kevin C. Knightly Kevin C. Knightly Kevin C. Knightly
Eric M. Sherbet Eric M. Sherbet Eric M. Sherbet Eric M. Sherbet
Michael R. McDonnell     Costa Panagos
      
PEO Total Compensation Amount [1] $ 29,151,752 $ 30,135,029 $ 28,615,851 $ 25,575,986
PEO Actually Paid Compensation Amount [2],[3] $ 42,292,899 5,961,064 88,421,980 44,629,998
Adjustment To PEO Compensation, Footnote [Text Block]

 

Year  Summary
Compensation
Table Total for PEO		  Exclusion of
Change in Pension
Value for PEO		  Exclusion of Stock
Awards and Option
Awards for PEO		  Inclusion of
Pension Service
Cost for PEO		  Inclusion of Equity
Values for PEO		  Compensation
Actually Paid
to PEO
2023  $29,151,752  $(844,991)  $(21,157,852)  $258,365  $34,885,625  $42,292,899
2022  $30,135,029  $(420,742)  $(21,388,958)  $296,785  $(2,661,050)  $5,961,064
2021  $28,615,851  $(535,539)  $(18,534,470)  $314,052  $78,562,087  $88,421,980
2020  $25,575,986  $(898,824)  $(15,916,277)  $273,872  $35,595,242  $44,629,998

 

Year  Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of Year
for PEO		  Change in Fair
Value from Last
Day of Prior
Year to Last Day
of Year of
Unvested Equity
Awards for PEO		  Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that Vested
During Year for
PEO		  Change in Fair
Value from Last
Day of Prior
Year to Vesting
Date of
Unvested Equity
Awards that
Vested During
Year for PEO		  Fair Value at
Last Day of Prior
Year of Equity
Awards
Forfeited During
Year for PEO		  Value of
Dividends or
Other Earnings
Paid on Stock or
Option Awards
Not Otherwise
Included for
PEO		  Total -
Inclusion of
Equity Values
for PEO
2023  $22,020,972  $1,379,297  0  $11,485,356  0  0  $34,885,625
2022  $16,869,138  $(15,553,971)  0  $(3,976,217)  0  0  $(2,661,050)
2021  $34,647,149  $25,065,538  0  $18,849,400  0  0  $78,562,087
2020  $20,767,428  $8,585,982  0  $6,241,832  0  0  $35,595,242
      
Non-PEO NEO Average Total Compensation Amount [1] $ 4,523,047 5,007,016 4,395,745 2,887,147
Non-PEO NEO Average Compensation Actually Paid Amount [2],[3] $ 4,103,793 1,702,449 10,062,332 3,051,142
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]

 

Year  Average Summary
Compensation
Table Total for
Other NEOs		  Average Exclusion
of Change in
Pension Value
for Other NEOs		  Average Exclusion
of Stock Awards
and Option Awards
for Other NEOs		  Average Inclusion
of Pension Service
Cost for Other
NEOs		  Average Inclusion
of Equity Values
for Other NEOs		  Average
Compensation
Actually Paid to
Other NEOs
2023  $4,523,047  $(73,164)  $(3,228,937)  $17,778  $2,865,069  $4,103,793
2022  $5,007,016  $(46,106)  $(3,363,826)  $22,217  $83,148  $1,702,449
2021  $4,395,745  $(45,384)  $(2,548,372)  $23,204  $8,237,139  $10,062,332
2020  $2,887,147  $(60,943)  $(1,728,351)  $7,049  $1,946,240  $3,051,142

 

Year  Average
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of Year
for Other NEOs		  Average Change
in Fair Value
from Last Day of
Prior Year to
Last Day of Year
of Unvested
Equity Awards
for Other NEOs		  Average
Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that Vested
During Year for
Other NEOs		  Average Change
in Fair Value
from Last Day of
Prior Year to
Vesting Date of
Unvested Equity
Awards that
Vested During
Year for Other
NEOs		  Average Fair
Value at Last
Day of Prior
Year of Equity
Awards
Forfeited During
Year for Other
NEOs		  Average Value
of Dividends or
Other Earnings
Paid on Stock or
Option Awards
Not Otherwise
Included for
Other NEOs		  Total - Average
Inclusion of
Equity Values
for Other NEOs
2023  $2,411,696  $153,127  0  $1,274,065  $(973,819)  0  $2,865,069
2022  $2,660,228  $(2,066,942)  0  $(510,138)  0  0  $83,148
2021  $4,763,789  $2,005,653  0  $1,467,697  0  0  $8,237,139
2020  $1,707,797  $336,729  0  $149,599  $(247,885)  0  $1,946,240
      
Compensation Actually Paid vs. Total Shareholder Return [Text Block]

Relationship Between Compensation Actually Paid and Performance Measures

 

In light of the significant weighting of long-term stock-based incentives in our pay mix due to the intended alignment between our named executive officers and stockholders, the Compensation Actually Paid values are significantly influenced by the value of IQVIA’s stock price. The table below reflects the relationship between the PEO and the average Other NEO compensation actually paid and the performance measures shown in the pay versus performance table from 2020 to 2023:

 

Period  Compensation
Actually Paid
to PEO		    Average
Compensation
Actually Paid to
Other NEOs		    IQVIA’s
TSR		    Peer
Group TSR		    Net
Income		    Adj. Diluted EPS
Growth		  
2020 to 2023  (5%)   35%   50%   71%   387%   60%

• Relationship Between Compensation Actually Paid to our PEO and the Average of the Compensation Actually Paid to the Other NEOs and the Company’s Cumulative TSR. From 2020 to 2023, the compensation actually paid to our PEO decreased by 5% and the average of the compensation actually paid to the Other NEOs increased by 35%, compared to a 50% increase in our TSR over the same time period.
      
Compensation Actually Paid vs. Net Income [Text Block]

Relationship Between Compensation Actually Paid and Performance Measures

 

In light of the significant weighting of long-term stock-based incentives in our pay mix due to the intended alignment between our named executive officers and stockholders, the Compensation Actually Paid values are significantly influenced by the value of IQVIA’s stock price. The table below reflects the relationship between the PEO and the average Other NEO compensation actually paid and the performance measures shown in the pay versus performance table from 2020 to 2023:

 

Period  Compensation
Actually Paid
to PEO		    Average
Compensation
Actually Paid to
Other NEOs		    IQVIA’s
TSR		    Peer
Group TSR		    Net
Income		    Adj. Diluted EPS
Growth		  
2020 to 2023  (5%)   35%   50%   71%   387%   60%

• Relationship Between Compensation Actually Paid to our PEO and the Average of the Compensation Actually Paid to the Other NEOs and the Company’s Net Income. From 2020 to 2023, the compensation actually paid to our PEO decreased by 5% and the average of the compensation actually paid to the Other NEOs increased by 35%, compared to a 387% increase in our Net Income over the same time period.
      
Compensation Actually Paid vs. Company Selected Measure [Text Block]

Relationship Between Compensation Actually Paid and Performance Measures

 

In light of the significant weighting of long-term stock-based incentives in our pay mix due to the intended alignment between our named executive officers and stockholders, the Compensation Actually Paid values are significantly influenced by the value of IQVIA’s stock price. The table below reflects the relationship between the PEO and the average Other NEO compensation actually paid and the performance measures shown in the pay versus performance table from 2020 to 2023:

 

Period  Compensation
Actually Paid
to PEO		    Average
Compensation
Actually Paid to
Other NEOs		    IQVIA’s
TSR		    Peer
Group TSR		    Net
Income		    Adj. Diluted EPS
Growth		  
2020 to 2023  (5%)   35%   50%   71%   387%   60%

• Relationship Between Compensation Actually Paid to our PEO and the Average of the Compensation Actually Paid to the Other NEOs and the Company’s Adjusted Diluted EPS Growth. From 2020 to 2023, the compensation actually paid to our decreased by 5% and the average of the compensation actually paid to the Other NEOs increased by 35%, compared to a 60% increase in our Adjusted Diluted EPS over the same time period.
      
Total Shareholder Return Vs Peer Group [Text Block]

Relationship Between Compensation Actually Paid and Performance Measures

 

In light of the significant weighting of long-term stock-based incentives in our pay mix due to the intended alignment between our named executive officers and stockholders, the Compensation Actually Paid values are significantly influenced by the value of IQVIA’s stock price. The table below reflects the relationship between the PEO and the average Other NEO compensation actually paid and the performance measures shown in the pay versus performance table from 2020 to 2023:

 

Period  Compensation
Actually Paid
to PEO		    Average
Compensation
Actually Paid to
Other NEOs		    IQVIA’s
TSR		    Peer
Group TSR		    Net
Income		    Adj. Diluted EPS
Growth		  
2020 to 2023  (5%)   35%   50%   71%   387%   60%

• Relationship Between the Company’s TSR and the Peer Group TSR. The TSR for the peer group disclosed in the table above increased by 71% from 2020 to 2023 as compared to the Company’s TSR, which increased by 50% over the same time period.
      
Tabular List [Table Text Block]

 

Performance Metrics
Adjusted Diluted EPS Growth (as defined in “Compensation Discussion & Analysis—Elements of Compensation—Short-Term Incentive Awards”, described on page 68)
Relative Total Stockholder Return (as defined in “Compensation Discussion & Analysis—Elements of Compensation— Long-Term Incentive Awards”, described on page 71)
Revenue (as defined in “Compensation Discussion & Analysis—Elements of Compensation—Short-Term Incentive Awards”, described on page 68)
Adjusted EBITDA (as defined in “Compensation Discussion & Analysis—Elements of Compensation—Short-Term Incentive Awards”, described on page 68)
      
Total Shareholder Return Amount [4] $ 149.75 132.61 182.60 115.96
Peer Group Total Shareholder Return Amount [4] 170.70 158.40 157.40 115.30
Net Income (Loss) Attributable to Parent $ 1,358,000,000 $ 1,091,000,000 $ 966,000,000 $ 279,000,000
Company Selected Measure Amount [5],[6] 0.004 0.125 0.407 0.005
Measure [Axis]: 1        
Pay vs Performance Disclosure [Table]        
Measure Name Adjusted Diluted EPS Growth      
Measure [Axis]: 2        
Pay vs Performance Disclosure [Table]        
Measure Name Relative Total Stockholder Return      
Measure [Axis]: 3        
Pay vs Performance Disclosure [Table]        
Measure Name Revenue      
Measure [Axis]: 4        
Pay vs Performance Disclosure [Table]        
Measure Name Adjusted EBITDA      
PEO [Member] | Exclusion of Change in Pension Value for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount $ (844,991) $ (420,742) $ (535,539) $ (898,824)
PEO [Member] | Exclusion of Stock Awards and Option Awards for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount (21,157,852) (21,388,958) (18,534,470) (15,916,277)
PEO [Member] | Inclusion of Pension Service Cost for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 258,365 296,785 314,052 273,872
PEO [Member] | Inclusion of Equity Values for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 34,885,625 (2,661,050) 78,562,087 35,595,242
PEO [Member] | Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 22,020,972 16,869,138 34,647,149 20,767,428
PEO [Member] | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 1,379,297 (15,553,971) 25,065,538 8,585,982
PEO [Member] | Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 0 0 0 0
PEO [Member] | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 11,485,356 (3,976,217) 18,849,400 6,241,832
PEO [Member] | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 0 0 0 0
PEO [Member] | Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Included for PEO        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount $ 0 $ 0 $ 0 $ 0
PEO [Member] | Ari Bousbib        
Pay vs Performance Disclosure [Table]        
PEO Name Ari Bousbib Ari Bousbib Ari Bousbib Ari Bousbib
Non-PEO NEO [Member] | Average Exclusion of Change in Pension Value for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount $ (73,164) $ (46,106) $ (45,384) $ (60,943)
Non-PEO NEO [Member] | Average Exclusion of Stock Awards and Option Awards for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount (3,228,937) (3,363,826) (2,548,372) (1,728,351)
Non-PEO NEO [Member] | Average Inclusion of Pension Service Cost for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 17,778 22,217 23,204 7,049
Non-PEO NEO [Member] | Average Inclusion of Equity Values for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 2,865,069 83,148 8,237,139 1,946,240
Non-PEO NEO [Member] | Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 2,411,696 2,660,228 4,763,789 1,707,797
Non-PEO NEO [Member] | Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 153,127 (2,066,942) 2,005,653 336,729
Non-PEO NEO [Member] | Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 0 0 0 0
Non-PEO NEO [Member] | Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount 1,274,065 (510,138) 1,467,697 149,599
Non-PEO NEO [Member] | Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount (973,819) 0 0 (247,885)
Non-PEO NEO [Member] | Average Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Included for Other NEOs        
Pay vs Performance Disclosure [Table]        
Adjustment to Compensation Amount $ 0 $ 0 $ 0 $ 0
Non-PEO NEO [Member] | Ron E. Bruehlman        
Pay vs Performance Disclosure [Table]        
PEO Name Ron E. Bruehlman Ron E. Bruehlman Ron E. Bruehlman Ron E. Bruehlman
Non-PEO NEO [Member] | W. Richard Staub III        
Pay vs Performance Disclosure [Table]        
PEO Name W. Richard Staub, III   W. Richard Staub, III W. Richard Staub, III
Non-PEO NEO [Member] | Costa Panagos        
Pay vs Performance Disclosure [Table]        
PEO Name Costa Panagos Costa Panagos    
Non-PEO NEO [Member] | Kevin C. Knightly        
Pay vs Performance Disclosure [Table]        
PEO Name Kevin C. Knightly Kevin C. Knightly Kevin C. Knightly Kevin C. Knightly
Non-PEO NEO [Member] | Eric M. Sherbet        
Pay vs Performance Disclosure [Table]        
PEO Name Eric M. Sherbet Eric M. Sherbet Eric M. Sherbet Eric M. Sherbet
Non-PEO NEO [Member] | Michael R. McDonnell        
Pay vs Performance Disclosure [Table]        
PEO Name       Michael R. McDonnell
[1] Ari Bousbib was our PEO for each year presented. The individuals comprising the Other NEOs for each year presented are listed below:
[2] Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Other NEOs as set forth below.  Equity values are calculated in accordance with FASB ASC Topic 718.  Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.
[3] The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v)(2)(iii) of Regulation S-K and do not reflect compensation actually earned, realized or received by the PEO or Other NEOs.  These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
[4] The peer group for each listed fiscal year consists of the companies listed as our compensation benchmarking peer group in the Compensation Discussion & Analysis specific for that fiscal year. For 2020 and 2021 the companies included Bausch Health Companies Inc., Boston Scientific Corporation, Cognizant Technology Solutions Corporation, Fiserv, Inc., Laboratory Corporation of America Holdings, Nielsen Holdings plc, Quest Diagnostics Incorporated, Regeneron Pharmaceuticals, Inc., Salesforce, Inc., S&P Global Inc., and Thomson Reuters Corporation (but excludes Allergan plc, acquired by AbbVie Inc. on May 8, 2020). For 2022, all of these companies were included except Nielsen Holdings plc. For 2023, the companies included AbbVie Inc., Accenture plc, Agilent Technologies, Inc., Amgen Inc., Avantor, Inc., Biogen Inc., Bristol Myers Squibb Co., Cognizant Technology Solutions Corp., Danaher Corporation, Eli Lilly & Co., Gartner, Inc., Gilead Sciences, Inc., International Business Machines Corp., ICON Plc, Laboratory Corp of America Holdings, Merck & Co., Inc., Moderna, Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals Inc., and Zoetis Inc.
[5] Adjusted Diluted EPS Growth was chosen from the following four most important financial performance measures used by the Company to link compensation actually paid to the PEO and other NEOs in 2023 to the Company’s performance:
[6] The Company has identified Adjusted Diluted EPS Growth as the company-selected measure for the pay versus performance disclosure, as it represents the most important financial performance measure used to link compensation actually paid to the PEO and the Other NEOs in 2023 to the Company’s performance. See Appendix A in this Proxy Statement for a reconciliation of Adjusted Diluted EPS Growth, a non-GAAP measure, to the most directly comparable GAAP measure.
v3.24.0.1
Pay versus Performance (Details) - $ / shares
 12 Months Ended 48 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2023
Closing share price percentage of 52-week high 95.67% 72.52% 98.79% 98.99%  
Compensation Actually Paid to PEO, percentage change         (5.00%)
Average Compensation Actually Paid to Other NEOs, percentage change         35.00%
IQVIA’s TSR, percentage change         50.00%
Peer Group TSR, percentage change         71.00%
Net Income, percentage change         387.00%
Adj. Diluted EPS Growth, percentage change         60.00%
Minimum [Member]          
Stock price $ 167.42 $ 165.75 $ 170.00 $ 81.79  
Maximum [Member]          
Stock price $ 241.86 $ 282.52 $ 285.61 $ 180.99